Effects of anesthesia monitoring on trachea extubatio

Phase 2

• Conditions: Ischaemic heart diseases.; Ischaemic heart diseases; I20-I25

• Registration Number: IRCT20161220031487N7
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 March 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Candidate for elective coronary artery bypass grafting operation
Body mass index of 18-25 kg/m2
LVEF>35%

Exclusion Criteria

Receiving inotropes for hemodynamics support before operation
Needing reoperation due to surgery-related complications such as bleeding
Not cooperating in the early post-operative days
Myocardial Infarction in the 7 recent days
Emphysema
Needing reoperation

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Systolic blood pressure. Timepoint: Intensive care unit entrance. Method of measurement: Barometer and vital sign monitoring device.;Use of anesthetics. Timepoint: During operation. Method of measurement: Calculating and registering the amount of the medication used.;Using inotropes. Timepoint: In operation room and in ICU. Method of measurement: Calculating and registering the amount of medication used.;Diastolic blood pressure. Timepoint: Intensive care unit entrance. Method of measurement: Barometer and vital sign monitoring device.;Heart rate. Timepoint: Intensive care unit entrance. Method of measurement: Vital sign monitoring device.

Secondary Outcome Measures

Name	Time	Method
Arterial blood gas analysis. Timepoint: Before anesthesia induction and on intensive care unit entrance. Method of measurement: Blood gas analysis device.